551 related articles for article (PubMed ID: 18669460)
1. Variations in quality of care for men with early-stage prostate cancer.
Spencer BA; Miller DC; Litwin MS; Ritchey JD; Stewart AK; Dunn RL; Gay EG; Sandler HM; Wei JT
J Clin Oncol; 2008 Aug; 26(22):3735-42. PubMed ID: 18669460
[TBL] [Abstract][Full Text] [Related]
2. Treatment choice and quality of care for men with localized prostate cancer.
Miller DC; Spencer BA; Ritchey J; Stewart AK; Dunn RL; Sandler HM; Wei JT; Litwin MS
Med Care; 2007 May; 45(5):401-9. PubMed ID: 17446826
[TBL] [Abstract][Full Text] [Related]
3. The quality of surgical pathology care for men undergoing radical prostatectomy in the U.S.
Miller DC; Spencer BA; Shah RB; Ritchey J; Stewart AK; Gay EG; Dunn RL; Wei JT; Litwin MS
Cancer; 2007 Jun; 109(12):2445-53. PubMed ID: 17492683
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the quality of medical care among patients with early stage prostate cancer undergoing expectant management in the United States.
Ritchey J; Gay EG; Spencer BA; Miller DC; Wallner LP; Stewart AK; Dunn RL; Litwin MS; Wei JT
J Urol; 2012 Sep; 188(3):769-74. PubMed ID: 22818140
[TBL] [Abstract][Full Text] [Related]
5. Quality-of-care indicators for early-stage prostate cancer.
Spencer BA; Steinberg M; Malin J; Adams J; Litwin MS
J Clin Oncol; 2003 May; 21(10):1928-36. PubMed ID: 12743145
[TBL] [Abstract][Full Text] [Related]
6. The National Cancer Data Base report on race, age, and region variations in prostate cancer treatment.
Mettlin CJ; Murphy GP; Cunningham MP; Menck HR
Cancer; 1997 Oct; 80(7):1261-6. PubMed ID: 9317177
[TBL] [Abstract][Full Text] [Related]
7. A nationwide charge comparison of the principal treatments for early stage prostate carcinoma.
Brandeis J; Pashos CL; Henning JM; Litwin MS
Cancer; 2000 Oct; 89(8):1792-9. PubMed ID: 11042575
[TBL] [Abstract][Full Text] [Related]
8. Assessing the quality of prostate cancer care.
Penson DF
Curr Opin Urol; 2008 May; 18(3):297-302. PubMed ID: 18382239
[TBL] [Abstract][Full Text] [Related]
9. Use of quality indicators to evaluate the care of patients with localized prostate carcinoma.
Miller DC; Litwin MS; Sanda MG; Montie JE; Dunn RL; Resh J; Sandler H; Wei JT
Cancer; 2003 Mar; 97(6):1428-35. PubMed ID: 12627506
[TBL] [Abstract][Full Text] [Related]
10. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
Nieder AM; Porter MP; Soloway MS
J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
[TBL] [Abstract][Full Text] [Related]
11. Predictors of fatigue after treatment for prostate cancer.
Maliski SL; Kwan L; Orecklin JR; Saigal CS; Litwin MS
Urology; 2005 Jan; 65(1):101-8. PubMed ID: 15667873
[TBL] [Abstract][Full Text] [Related]
12. Quality of care indicators for prostate cancer: progress toward consensus.
Miller DC; Saigal CS
Urol Oncol; 2009; 27(4):427-34. PubMed ID: 19573774
[TBL] [Abstract][Full Text] [Related]
13. Using QRRO survey data to assess compliance with quality indicators for breast and prostate cancer.
Owen JB; White JR; Zelefsky MJ; Wilson JF
J Am Coll Radiol; 2009 Jun; 6(6):442-7. PubMed ID: 19467491
[TBL] [Abstract][Full Text] [Related]
14. Implementation of the Quality Oncology Practice Initiative at a university comprehensive cancer center.
Blayney DW; McNiff K; Hanauer D; Miela G; Markstrom D; Neuss M
J Clin Oncol; 2009 Aug; 27(23):3802-7. PubMed ID: 19487377
[TBL] [Abstract][Full Text] [Related]
15. Patterns of surgical care for prostate cancer in NSW, 1993-2002: rural/urban and socio-economic variation.
Hayen A; Smith DP; Patel MI; O'Connell DL
Aust N Z J Public Health; 2008 Oct; 32(5):417-20. PubMed ID: 18959543
[TBL] [Abstract][Full Text] [Related]
16. Measuring the quality of care for localized prostate cancer.
Miller DC; Montie JE; Wei JT
J Urol; 2005 Aug; 174(2):425-31. PubMed ID: 16006858
[TBL] [Abstract][Full Text] [Related]
17. Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States?
Malin JL; Schneider EC; Epstein AM; Adams J; Emanuel EJ; Kahn KL
J Clin Oncol; 2006 Feb; 24(4):626-34. PubMed ID: 16401682
[TBL] [Abstract][Full Text] [Related]
18. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
[TBL] [Abstract][Full Text] [Related]
19. Geographic and socioeconomic variation in the treatment of prostate cancer.
Krupski TL; Kwan L; Afifi AA; Litwin MS
J Clin Oncol; 2005 Nov; 23(31):7881-8. PubMed ID: 16204005
[TBL] [Abstract][Full Text] [Related]
20. [Curative treatment of prostatic cancer in Norway in 1998 and 2001].
Kvåle R; Skarre E; Tønne A; Kyrdalen AE; Norstein J; Angelsen A; Wahlqvist R; Fosså SD
Tidsskr Nor Laegeforen; 2006 Mar; 126(7):912-6. PubMed ID: 16554883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
